Evidence map›Paper›PMID 42440459›Full record

ArticleFrontiers in oncology2026

Deep transfer learning for breast cancer detection in underserved regions.

Mahmoud Obaid, Suhail M Odeh, Huthaifa I Ashqar, Allam Abumwais, Rami Hodrob

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mahmoud ObaidComputer System Engineering Department, Arab American University, Jenin, Palestine.
Suhail M OdehSoftware Engineering Department, Bethlehem University, Bethlehem, Palestine.
Huthaifa I AshqarAI and Data Science Department, Arab American University, Jenin, Palestine.
Allam AbumwaisComputer System Engineering Department, Arab American University, Jenin, Palestine.
Rami HodrobComputer System Engineering Department, Arab American University, Jenin, Palestine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objective: In Palestine, breast cancer is the leading cancer in women, constituting more than 34% of all cancer cases in women and 12% of all cancer related deaths. The Palestinian health care system is suffering from shortages, lack of advanced diagnostic equipment, among other issues. This study proposes a new two-step deep learning method for breast cancer detection in mammograms, with a particular focus on the potential of using it in low-resource settings like Palestine. The framework categorizes the tumor and adds a cost-effective and scalable diagnostic support tool that differentiates benign from malignant tumors. Methods: The proposed framework operates in two sequential stages. First, a U-Net architecture with a VGG16 encoder backbone, trained from scratch on the CBIS-DDSM mammography dataset, performs lesion segmentation. The CBIS-DDSM training set comprised 2,206 mammograms and the test set 576 images, all with ground truth binary masks. Second, a VGG16 classification model initialized with ImageNet pretrained weights classifies the segmented regions as benign or malignant. The classifier was tested on a subset of 34 patients from the Palestine Hospital dataset (12 benign, 22 malignant), which was used exclusively for external testing, in which no Palestine data were used in training or validation. Results: The U-Net segmentation model achieved a mean IoU of 0.70, Dice coefficient of 0.74, precision of 0.78, and recall of 0.71 on the CBIS-DDSM test set. The VGG16 classifier achieved 91% accuracy, 0.91 precision, 0.95 recall (malignant class), and AUC of 0.97 on the Palestine evaluation subset. Comparison against ResNet50 (85% accuracy) and MobileNet (82%) confirms the superiority of the proposed approach. Conclusion: The present study proposes a promising proof-of-concept deep learning pipeline for breast cancer detection. The results show that it is feasible in a low-resource environment, but would need to be validated on a larger annotated local dataset before deployment. The framework provides a guidance for scalable and cost-effective diagnostic assistance in underserved areas.

Indexed as

biopsybreast cancerCNNdetectionmachine learningmammographysegmentationtumor

Identifiers

PMID42440459
PMCPMC13333434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.